| URL | Priority | Change frequency | Last modified (GMT) |
|---|---|---|---|
| https://astx.com/tas1553-oral-small-molecule-ribonucleotide-reductase-rnr-inhibitor-hematological-malignancies/ | 60% | Weekly | 2023-09-06 17:32 |
| https://astx.com/azacitidine-and-cedazuridine-astx030-oral-dnmt-inhibitor-hematological-malignancies/ | 60% | Weekly | 2023-09-06 17:31 |
| https://astx.com/tas1440-oral-lsd1-inhibitor-hematological-malignancies/ | 60% | Weekly | 2023-09-06 17:31 |
| https://astx.com/research-development/clinical-pipeline/tolinapant-astx660-dual-iap-antagonist-solid-tumors-lymphomas/ | 60% | Weekly | 2023-09-06 17:30 |